Data suggests no increase in pediatric hepatitis, adenovirus above pre-pandemic levels

Data reported in Morbidity and Mortality Weekly Report did not demonstrate an increase in pediatric hepatitis or adenovirus types 40/41 above pre-COVID-19 pandemic baseline levels.“Following identification of pediatric hepatitis cases of unknown etiology in the United States and the United Kingdom, CDC issued a request in April 2022 for U.S. providers to report additional cases,” Anita K. Kambhampati, MPH, of the division of viral diseases at the CDC National Center for Immunization and Respiratory Diseases, and colleagues wrote. “Many reported cases had test resultsRead More

Generated by Feedzy